Results 271 to 280 of about 206,627 (318)

Measuring lifetime alcohol exposure: A scoping review and implications for translational research and alcohol‐related harm

Addiction, EarlyView.
Abstract Background and aims Understanding lifetime alcohol exposure is fundamental to appreciating the risks of alcohol dependence and the multiplicity of alcohol‐related harms, such as cirrhosis. However, most research relies on self‐reported alcohol use measures that rarely extend beyond recent consumption.
Andrew J. Palmer, Jason P. Connor, Gerald Holtmann, John B. Saunders, Katie Rice, Jeremy Yeo, Andrea Huang, Paul J. Clark   +7 more
wiley   +1 more source

Evaluating the optimal duration of medication treatment for opioid use disorder

Addiction, EarlyView.
Abstract Background and aims Clinicians have little guidance on the ideal length of time patients should remain on medication treatment for opioid use disorder (MOUD) before being able to safely discontinue MOUD. This study estimated how the risk of all‐cause mortality changes with the duration of MOUD, controlling for patient characteristics that ...
Corey J. Hayes, Rebecca A. Raciborski, Mahip Acharya, Nahiyan Bin Noor, Edward V. Nunes, T. John Winhusen   +5 more
wiley   +1 more source

Characteristics of methamphetamine‐related deaths in the United Kingdom, 1997–2024

Addiction, EarlyView.
Abstract Background and aims People who use methamphetamine have a standardised mortality ratio 6.8 times greater than the general population, with several countries reporting concerning increases in methamphetamine‐related mortality over the past decade.
Emmert Roberts, Rebecca McKetin, Caroline Copeland   +2 more
wiley   +1 more source

In memoriam: Remembering Professor Roger Nordmann, May 24, 1926-January 24, 2014. [PDF]

, 2014
Schuckit, Marc A
core  

Sample size requirements to evaluate policies in addiction research using interrupted time series analysis (ITS): Tools and guidance

Addiction, EarlyView.
Abstract Formal power calculations are rarely presented in interrupted time‐series (ITS) studies due to their technical complexity, creating a significant gap in methodological rigor. This paper aimed to make power and sample size determination more accessible for researchers, particularly in the field of addiction, by providing a suite of practical ...
Emma Beard, Jamie Brown, Lion Shahab
wiley   +1 more source

Socio‐economic differences in the effectiveness of pharmacotherapy use in alcohol use disorder: A cohort study of 148 626 individuals in Sweden

Addiction, EarlyView.
Abstract Aim To examine the socioeconomic differences in the effectiveness of alcohol use disorders (AUD) pharmacotherapy and risk of AUD hospitalisation. Design A prospective register‐based cohort study. Setting Sweden. Participants Individuals who were registered as living in Sweden in 2005 (16–64 years) with a first‐time AUD diagnosis and complete ...
Devy L. Elling, Emelie Thern, Lluís Mangot‐Sala, Jari Tiihonen, Anders Hammarberg, Daniel Falkstedt, Heidi Taipale   +6 more
wiley   +1 more source

Commentary on Borodovsky et al.: Enhancing research on THC quantification—Consumer awareness through accurate labelling

Addiction, Volume 120, Issue 4, Page 686-687, April 2025.
Rachel Lees Thorne, Tom P. Freeman
wiley   +1 more source

Efficacy of cognitive behavioral therapy‐based smartphone app for smoking cessation in China: A randomized controlled trial

Addiction, EarlyView.
Abstract Background and aims Smoking is the leading preventable cause of premature death in China, yet less than 10% of smokers seeking to quit receive treatment. This study aimed to test the efficacy of a cognitive behavioral therapy (CBT)‐based smoking cessation intervention (‘Smokefree Life’) via a smartphone app in China. Design A digital, parallel,
Jinsong Tang, Xiaocong Liu, Shanshan Chen, Yunkai Sun, Minzhe Zhu, Zitang Zhou, Yueheng Liu, Jie Yang, Wei Chen, Yanhui Liao   +9 more
wiley   +1 more source

Contingency management interventions for substance use and addictive behaviours: Review of the United Kingdom evidence base

Addiction, EarlyView.
Abstract Background and aims Substance use and other addictive behaviours including gambling remain major public health concerns in the UK. Despite the effectiveness of substance use treatment approaches, treatment adherence and success rates remain low.
Carol‐Ann Getty, Tricia McQuarrie, Eileen Brobbin   +2 more
wiley   +1 more source

Zero tolerance for 0%? How should clinicians and other practitioners respond to the use of alcohol‐free and low‐alcohol products in higher risk groups

Addiction, EarlyView.
Abstract Alcohol‐free and low‐alcohol drinks (no/lo drinks) are now widely available and popular with consumers in high‐income countries; however, it is unclear whether clinicians and others working to prevent or treat severe alcohol‐related health problems should take a zero‐tolerance approach to these alcohol‐like products or encourage patients to ...
John Holmes, Christopher K. Oldroyd, Colin Drummond, Matt Field, Inge Kersbergen, Michael E. D. Allison   +5 more
wiley   +1 more source